2015
DOI: 10.1002/anie.201507281
|View full text |Cite|
|
Sign up to set email alerts
|

The cis‐Diammineplatinum(II) Complex of Curcumin: A Dual Action DNA Crosslinking and Photochemotherapeutic Agent

Abstract: [Pt(cur)(NH3)2](NO3) (1), a curcumin-bound cis-diammineplatinum(II) complex, nicknamed Platicur, as a novel photoactivated chemotherapeutic agent releases photoactive curcumin and an active platinum(II) species upon irradiation with visible light. The hydrolytic instability of free curcumin reduces upon binding to platinum(II). Interactions of 1 with 5'-GMP and ct-DNA indicated formation of platinum-bound DNA adducts upon exposure to visible light (λ=400-700 nm). It showed apoptotic photocytotoxicity in cancer… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

4
90
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 114 publications
(94 citation statements)
references
References 30 publications
4
90
0
Order By: Relevance
“…This results in the release of a ligand and generation of reactive species, which can both contribute to the therapeutic effect . Complexes with different metals/configuration, including a Pt II ‐curcumin derivative, have also been investigated for photosubstitution reactions …”
Section: Photoactivated Chemotherapy (Pact) Agentsmentioning
confidence: 99%
See 1 more Smart Citation
“…This results in the release of a ligand and generation of reactive species, which can both contribute to the therapeutic effect . Complexes with different metals/configuration, including a Pt II ‐curcumin derivative, have also been investigated for photosubstitution reactions …”
Section: Photoactivated Chemotherapy (Pact) Agentsmentioning
confidence: 99%
“…[21] Complexes with different metals/ configuration, including a Pt II -curcumin derivative, have also been investigated for photosubstitution reactions. [28] 3) Bioactive ligand release: Several complexes based on Mn I , Re I and Cr III centres can release, upon irradiation, small bioactive molecules such as NO [29] and CO. [30] Ru II complexes acting as photocages for enzyme inhibitors [31] or neurotransmitters [32] have also been investigated. 4) Ligand photocleavage: For this class of complexes, photoactivation is ligand-centred and results in the formation…”
Section: Photoactivated Chemotherapy (Pact) Agentsmentioning
confidence: 99%
“…Near-IR light-triggered uncaging of C4'-amine-substitued cyanine analogues was recently demonstrated by Schnermann and co-workers. [16] This finding,coupled with the observations suggesting that the Pt II À Obonds are photolabile, [11] prompted us to examine the photodegradation pathways of 1.W e performed the stability studies in solvents relevant to cellculture settings,t hat is,1 %D MSO in PBS or DMEM at biological pH of 7.4. Thephotoreactivity of 1 and IR797-acac was demonstrated by the rapid decrease in absorbance at 790 nm and ac oncomitant gradual increase at 410 nm when exposed to near-IR light (Figure 1b;Supporting Information, Figure S10).…”
mentioning
confidence: 53%
“…In this article, we report for the first time that supramolecular nanomaterials can serve as an excellent nanoplatform to develop superior radiosensitizers. Curcumin, a polyphenol from the rhizomes of curcuma longa, was selected as the model drug in this work, as it is in clinical use and there have been several studies demonstrating that curcumin has potential radiosensitization effect. According to the literature, however, the SER10 values of curcumin or currently reported curcumin‐based nanoformulations are no more than 1.6 in various kinds of cancer cells .…”
Section: Introductionmentioning
confidence: 99%